Results 221 to 223 of about 44,829 (223)

Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1

Amino Acids, 2014
G. Pantouris, Martynas Serys, H. Yuasa, H. Ball, C. Mowat   +4 more
semanticscholar   +1 more source

Abstract CT116: BMS-986205, an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic (PD) activity, alone and in combination with nivolumab (nivo) in advanced cancers in a phase 1/2a trial

, 2017
L. Siu, K. Gelmon, Q. Chu, R. Pachynski, O. Alese, P. Basciano, Walker Justine Kamilah, Priyam Mitra, Li Zhu, P. Phillips, J. Hunt, J. Desai   +11 more
semanticscholar   +1 more source

Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.

Journal of Medicinal Chemistry, 2012
U. Röhrig, S. R. Majjigapu, A. Grosdidier, Sylvian Bron, V. Stroobant, L. Pilotte, D. Colau, P. Vogel, B. J. Van den Eynde, V. Zoete, O. Michielin   +10 more
semanticscholar   +1 more source